(ACLX) Arcellx - Performance 9.1% in 12m
Compare ACLX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
60.93%
#8 in Group
Rel. Strength
77.35%
#1803 in Universe
Total Return 12m
9.14%
#38 in Group
Total Return 5y
242.56%
#7 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -3.15%
12th Percentile in Group
12m Total Return: ACLX (9.1%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ACLX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ACLX
| Total Return (including Dividends) | ACLX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.72% | 2.02% | 2.87% |
| 3 Months | -14.10% | -15.44% | -6.42% |
| 12 Months | 9.14% | -14.02% | 9.87% |
| 5 Years | 242.56% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ACLX | XBI | S&P 500 |
| 1 Month | 7.80% | 57% | 89.4% |
| 3 Months | -35.4% | -82.3% | -72% |
| 12 Months | 28.9% | -53.1% | 49.3% |
| 5 Years | 93.7% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #135 | -4.64% | -5.43% |
| 3 Month | #49 | 1.58% | -8.21% |
| 12 Month | #39 | 26.9% | -0.67% |
| 5 Years | #6 | 306% | 160% |
FAQs
Does ACLX Arcellx outperforms the market?
Yes,
over the last 12 months ACLX made 9.14%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months ACLX made -14.10%, while XBI made -15.44%.
Over the last 3 months ACLX made -14.10%, while XBI made -15.44%.
Performance Comparison ACLX vs Indeces and Sectors
ACLX vs. Indices ACLX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.8% | -5.59% | -40.8% | -0.73% |
| US NASDAQ 100 | QQQ | -12.0% | -7.43% | -41.2% | -2.18% |
| US Dow Jones Industrial 30 | DIA | -12.1% | -4.33% | -39.8% | 2.77% |
| German DAX 40 | DAX | -13.9% | -22.0% | -66.4% | -15.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.4% | -8.99% | -40.1% | 3.51% |
| Hongkong Hang Seng | HSI | -15.3% | -18.9% | -50.3% | -2.95% |
| India NIFTY 50 | INDA | -9.38% | -5.0% | -42.7% | 6.81% |
| Brasil Bovespa | EWZ | -13.8% | -14.3% | -50.0% | 15.6% |
ACLX vs. Sectors ACLX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -12.0% | -6.39% | -47.0% | -11.2% |
| Consumer Discretionary | XLY | -12.7% | -6.23% | -38.6% | -4.91% |
| Consumer Staples | XLP | -11.4% | -4.74% | -47.7% | 1.58% |
| Energy | XLE | -12.8% | -2.80% | -34.8% | 18.9% |
| Financial | XLF | -12.4% | -8.29% | -46.7% | -12.4% |
| Health Care | XLV | -7.98% | 1.66% | -35.6% | 15.1% |
| Industrial | XLI | -13.3% | -10.1% | -41.8% | -0.85% |
| Materials | XLB | -11.8% | -7.43% | -36.8% | 15.2% |
| Real Estate | XLRE | -11.4% | -8.84% | -43.2% | -4.32% |
| Technology | XLK | -12.7% | -9.46% | -38.6% | 2.14% |
| Utilities | XLU | -12.8% | -8.34% | -48.6% | -6.77% |
| Aerospace & Defense | XAR | -12.3% | -12.1% | -50.1% | -16.0% |
| Biotech | XBI | -3.69% | -4.74% | -19.8% | 23.2% |
| Homebuilder | XHB | -11.3% | -5.79% | -27.2% | 18.9% |
| Retail | XRT | -11.9% | -6.31% | -34.5% | 13.5% |